Kck Ltd. - Net Worth and Insider Trading
Kck Ltd. Net Worth
The estimated net worth of Kck Ltd. is at least $60 Million dollars as of 2024-12-27. Kck Ltd. is the 10% Owner of NeuroPace Inc and owns about 5,270,845 shares of NeuroPace Inc (NPCE) stock worth over $60 Million. Kck Ltd. is also the 10% Owner of Aileron Therapeutics Inc and owns about 32,341 shares of Aileron Therapeutics Inc (ALRN) stock worth over $72,767. Details can be seen in Kck Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kck Ltd. has not made any transactions after 2024-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kck Ltd.
Kck Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kck Ltd. owns 3 companies in total, including Aileron Therapeutics Inc (ALRN) , NeuroPace Inc (NPCE) , and Sight Sciences Inc (SGHT) .
Click here to see the complete history of Kck Ltd.’s form 4 insider trades.
Insider Ownership Summary of Kck Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 10 percent owner |
| NPCE | NeuroPace Inc | 2024-10-25 | 10 percent owner |
| SGHT | Sight Sciences Inc | 2021-07-14 | 10 percent owner |
Kck Ltd. Latest Holdings Summary
Kck Ltd. currently owns a total of 2 stocks. Among these stocks, Kck Ltd. owns 5,270,845 shares of NeuroPace Inc (NPCE) as of October 25, 2024, with a value of $60 Million and a weighting of 99.88%. Kck Ltd. also owns 32,341 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $72,767 and a weighting of 0.12%.
Latest Holdings of Kck Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NPCE | NeuroPace Inc | 2024-10-25 | 5,270,845 | 11.35 | 59,824,091 |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 32,341 | 2.25 | 72,767 |
Holding Weightings of Kck Ltd.
Kck Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Kck Ltd. has made a total of 7 transactions in NeuroPace Inc (NPCE) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in NeuroPace Inc is the sale of 224,138 shares on October 25, 2024, which brought Kck Ltd. around $1 Million.
According to the SEC Form 4 filings, Kck Ltd. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 10,000 shares on July 5, 2017, which cost Kck Ltd. around $3 Million.
Insider Trading History of Kck Ltd.
- 1
Kck Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Kck Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kck Ltd. is 18.28%. GuruFocus also compares Kck Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kck Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kck Ltd.'s insider trading performs compared to the benchmark.
Performance of Kck Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.38 | | | | | |
| Relative Return to S&P 500(%) | -3.2 | | | | | |
Kck Ltd. Ownership Network
Kck Ltd. Owned Company Details
What does Aileron Therapeutics Inc do?
Who are the key executives at Aileron Therapeutics Inc?
Kck Ltd. is the 10 percent owner of Aileron Therapeutics Inc. Other key executives at Aileron Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and 10 percent owner Muneer A Satter .
Aileron Therapeutics Inc (ALRN) Insider Trades Summary
Over the past 18 months, Kck Ltd. made no insider transaction in Aileron Therapeutics Inc (ALRN). Other recent insider transactions involving Aileron Therapeutics Inc (ALRN) include a net sale of 95,059 shares made by , and a net purchase of 5,701 shares made by James Brian Windsor .
In summary, during the past 3 months, insiders sold 0 shares of Aileron Therapeutics Inc (ALRN) in total and bought 400 shares, with a net purchase of 400 shares. During the past 18 months, 95,059 shares of Aileron Therapeutics Inc (ALRN) were sold and 5,701 shares were bought by its insiders, resulting in a net sale of 89,358 shares.
Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aileron Therapeutics Inc Insider Transactions
Kck Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Kck Ltd.. You might contact Kck Ltd. via mailing address: Craigmuir Chambers, Road Town, Tortola D8 Vg1110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
